Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-022415
Filing Date
2022-08-12
Accepted
2022-08-12 17:15:56
Documents
1
Period of Report
2022-08-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 16776
  Complete submission text file 0001493152-22-022415.txt   18152
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18 BOSTON MA 02116
Business Address
Dake Benjamin T (Reporting) CIK: 0001869248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 221161224